At this level, the mode of action of BRT (Figure 6) is reminiscent of that of the quassinoid brusatol, which is also an inhibitor of Nrf2 and c-Myc, which increases HIF-1α degradation to induce cell death of cancer cells [108]. The gene discussed is TYRO3; the disease is cancer.